CompletedEUCTR 2014-000520-14

Prednisolone addition for atients with recent onset psychotic disorder: the role of immune-modulating strategies in the treatment of psychosis.

This historical record does not confirm current site availability.

Historical research recordBelgium + NetherlandsSchizophrenia

The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations: Belgium · Netherlands
Study phase: Phase 2

Get this study by email

Study clarity

Study information

Study start dateNot clearly listed

Recruitment status: Completed
Enrollment listed in the registry: 90
Sponsor: University Medical Center Utrecht
Sponsor type: Hospital / academic medical center
Study type: Drug
Intervention type: Drug
Study phase: Phase 2
Locations: Belgium, Netherlands
Age range: Not clearly listed
Official registry ID: EUCTR 2014-000520-14
Official title: Show the full official title
Prednisolone addition for atients with recent onset psychotic disorder: the role of immune-modulating strategies in the treatment of psychosis.

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Belgium · Netherlands

Registry details

Historical country statuses

Belgium — Completed
Netherlands — Completed

Interested in joining this study?

FAQ

Questions about this study

Who is behind this study?

The study sponsor is University Medical Center Utrecht, a hospital or academic medical center.

Want to explore more studies?

Explore studies